- NCIt
- C36310
Loading cancer entity…
Loading cancer entity…
Clinical trials
222 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (24)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04512209 | Characterization of Biophysical Stromal Properties in Human Cancer: Towards Personalized Computational Oncology(DCE-MRI) | completed | N/A | 22 | University Hospital, GhentOTHER | 1 | Sep 21, 2026 | clinicaltrials |
| NCT06812871 | High-dose Furmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Meningeal Metastasis | completed | Phase 2 | 46 | Sun Yat-sen UniversityOTHER | 1 | Aug 14, 2026 |
| clinicaltrials |
| NCT06237582 | Inferior Epigastric Lymp Node (IELN) Basin as a Possible Systemic Metastatic Pathway of Ovarian Peritoneal Metastases(OvEpiLyPath) | completed | N/A | 20 | Jules Bordet InstituteOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT05185947 | Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis | completed | Phase 2 | 21 | National Cancer Institute (NCI)NIH | 1 | Jun 25, 2026 | clinicaltrials |
| NCT02759588 | Olvi-Vec Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian Cancer | completed | Phase 1 / Phase 2 | 46 | Genelux CorporationINDUSTRY | 1 | Jun 12, 2026 | clinicaltrials |
| NCT03732768 | Study of Radspherin® in Recurrent Ovarian Cancer Subjects With Peritoneal Carcinomatosis | completed | Phase 1 | 21 | Oncoinvent Solutions ASINDUSTRY | 3 | Apr 17, 2026 | clinicaltrials |
| NCT07478107 | Molecular Citology to Detect Free Cancer Cells in Peritoneal Fluid(OSNA) | completed | — | 108 | University of Campania Luigi VanvitelliOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT06144853 | The PIPAC-OPC7 Study: The Use of PET/CT Scans as a Method of Evaluation in Patients Treated With PIPAC, a Pilot Study. | completed | — | 34 | Odense University HospitalOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT04343573 | Proton Craniospinal Radiation Therapy vs. Partial Photon Radiation Therapy for Leptomeningeal Metastasis From Solid Tumors | completed | Phase 2 | 102 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT06592092 | Clinical Study of QH104 Cell Injection for the Treatment of Meningeal Metastases of B7H3+ Solid Tumors | completed | N/A | 3 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT06839378 | Flura-seq for Evaluating the Effects of Different Hyperthermic Intraperitoneal Chemotherapy Regimens on the Transcriptome of Pseudomyxoma Peritonei | completed | N/A | 36 | Beijing Tsinghua Chang Gung HospitalOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT01373710 | Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis(HIT) | completed | Phase 1 / Phase 2 | 34 | Institut CurieOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT02939300 | Ipilimumab and Nivolumab in Leptomeningeal Metastases | completed | Phase 2 | 18 | Massachusetts General HospitalOTHER | 1 | Nov 14, 2025 | clinicaltrials |
| NCT05644249 | PIPAC and FOLFOX for Gastric Cancer Peritoneal Cancer | completed | N/A | 37 | Vilnius UniversityOTHER | 1 | Sep 24, 2025 | clinicaltrials |
| NCT04766502 | Bonds Between Circulating Tumoral ADN (ctDNA) and the Development of Peritoneal Carcinomatosis for Patients Under PIPAC(PIPADN) | completed | N/A | 20 | Institut de Cancérologie de LorraineOTHER | 1 | Jul 24, 2025 | clinicaltrials |
| NCT03508570 | Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis | completed | Phase 1 | 26 | M.D. Anderson Cancer CenterOTHER | 1 | May 22, 2025 | clinicaltrials |
| NCT05289908 | Intrathecal Pemetrexed for Leptomeningeal Metastasis | completed | Phase 1 / Phase 2 | 34 | The First Hospital of Jilin UniversityOTHER | 1 | May 4, 2025 | clinicaltrials |
| NCT01443260 | A Study of GL-ONC1, an Oncolytic Vaccinia Virus, in Patients With Advanced Peritoneal Carcinomatosis | completed | Phase 1 / Phase 2 | 9 | Genelux GmbHINDUSTRY | 1 | Apr 30, 2025 | clinicaltrials |
| NCT05340569 | Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma.(DWI-PDAC) | completed | N/A | 40 | Laval UniversityOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT06789224 | Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device(REMOVE) | completed | N/A | 136 | Lindis Bloodcare GmbHINDUSTRY | 1 | Jan 23, 2025 | clinicaltrials |
| NCT04950166 | A Study to Evaluate ONM100, an Intraoperative Fluor Imaging Agent for the Detection of Peri Mets | completed | Phase 2 | 51 | OncoNano Medicine, Inc.INDUSTRY | 1 | Nov 8, 2024 | clinicaltrials |
| NCT02040142 | HIPEC for Peritoneal Carcinomatosis | completed | Phase 2 | 51 | Albert Einstein College of MedicineOTHER | 1 | Oct 24, 2024 | clinicaltrials |
| NCT02891447 | Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer | completed | Phase 2 | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT03777943 | Role of the Peritoneal Microenvironment in the Pathogenesis and Spread of Colorectal Carcinomatosis(MMT) | completed | — | 53 | University Hospital, GhentOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT04744688 | Changes in Coagulation in Colorectal Cancer Patients Undergoing Surgical Treatment(CONTEST) | completed | — | 90 | University of AarhusOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT04898842 | Feasibility Study of a 4 Stage Bowel Obstruction Cancer Diet(BOUNCED) | completed | N/A | 30 | Royal Surrey County Hospital NHS Foundation TrustOTHER | 1 | Apr 10, 2024 | clinicaltrials |
| NCT05083338 | Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy | completed | — | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 13, 2024 | clinicaltrials |
| NCT03517852 | Intravital Microscopy (IVM) in Patients With Peritoneal Carcinomatosis (PC) | completed | N/A | 30 | Mayo ClinicOTHER | 1 | Jan 19, 2024 | clinicaltrials |
| NCT03618758 | Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6(IPLUS) | completed | Phase 1 / Phase 2 | 35 | Seoul National University Bundang HospitalOTHER | 1 | Dec 5, 2023 | clinicaltrials |
| NCT03304210 | PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian Cancer(PIPAC-nabpac) | completed | Phase 1 | 20 | University Hospital, GhentOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT05513183 | Severe Neutropenia After HIPEC Using Mitomycin-C | completed | — | 74 | Gangnam Severance HospitalOTHER | 1 | Aug 7, 2023 | clinicaltrials |
| NCT03520504 | Study of Proton Radiation to the Brain and Spinal Cord for Patients With Leptomeningeal Metastases | completed | Phase 1 | 24 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 23, 2022 | clinicaltrials |
| NCT01575730 | Cytoreduction Followed by Normothermic Versus Hyperthermic Intraperitoneal Intraoperative Chemoperfusion (HIPEC): a Study in Peritoneal Carcinomatosis | completed | Phase 2 | 45 | University Hospital, GhentOTHER | 1 | Dec 15, 2022 | clinicaltrials |
| NCT02179489 | Surgery With HIPEC in Treating Patients With a High Risk of Developing Colorectal Peritoneal Carcinomatosis | completed | N/A | 271 | Zhejiang UniversityOTHER | 1 | Jun 27, 2022 | clinicaltrials |
| NCT04904042 | Study of Safety and Efficiency of the Use of Neutral Argon Plasma in Cyto-reduction of Miliary Implants in the Peritoneal Surface.(Plasmajet) | completed | N/A | 10 | Maimónides Biomedical Research Institute of CórdobaOTHER | 1 | Jun 2, 2022 | clinicaltrials |
| NCT02833753 | Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRI | completed | Phase 1 | 14 | University of Massachusetts, WorcesterOTHER | 1 | May 31, 2022 | clinicaltrials |
| NCT04088786 | Phase I Trial HIPEC With Nal-irinotecan | completed | Phase 1 | 18 | Stony Brook UniversityOTHER | 1 | May 6, 2022 | clinicaltrials |
| NCT05300789 | Metachonous Peritoneal Carcinomatosis Incidence After Curative Surgery for pT4 Colon Cancer Patients | completed | — | 1,152 | Carlos Cerdán SantacruzOTHER | 1 | Mar 29, 2022 | clinicaltrials |
| NCT04879953 | Effect of the PIPAC on the Survival Rate of Patients With Peritoneal Carcinomatosis of Gastric Origin | completed | — | 46 | Association Francaise de ChirurgieOTHER | 1 | May 11, 2021 | clinicaltrials |
| NCT03956836 | Perioperative Coagulopathy in Patients Undergoing Cytoreductive Surgery and HIPEC Intraperitoneal Chemotherapy (HIPEC)(HIPEC-COAG) | completed | — | 46 | Hospitales Universitarios Virgen del RocíoOTHER | 1 | Mar 9, 2021 | clinicaltrials |
| NCT01713699 | Circulating Tumor Cells and Cytology in Cerebrospinal Fluid of Patients Clinically Suspected for Leptomeningeal Metastases | completed | N/A | 146 | The Netherlands Cancer InstituteOTHER | 1 | Jan 22, 2021 | clinicaltrials |
| NCT02784028 | Study in Patients With Peritoneal Carcinomatosis From CEA Overexpressing Digestive Cancer(FLUOCAR-1) | completed | N/A | 18 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Oct 20, 2020 | clinicaltrials |
| NCT03364907 | Clinical Pharmacology of Platinum-based Hyperthermic Intraperitoneal Chemotherapy(GUTOX) | completed | — | 20 | Radboud University Medical CenterOTHER | 1 | Oct 20, 2020 | clinicaltrials |
| NCT02604784 | Study of Efficacy and Safety of Laparoscopic Intra-abdominal Chemotherapy (PIPAC) Performed in Patients With Peritoneal Carcinomatosis From Colorectal, Ovarian, Gastric Cancer and Primary Peritoneal Tumors(PI-CaP) | completed | Phase 1 / Phase 2 | 105 | Fondazione del Piemonte per l'OncologiaOTHER | 1 | Sep 17, 2020 | clinicaltrials |
| NCT02071056 | Circulating Tumor DNA in Cerebrospinal Fluid as an Early Biomarker of Leptomeningeal Metastasis (LM) | completed | — | 5 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 18, 2020 | clinicaltrials |
| NCT02151448 | αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies | completed | Phase 1 / Phase 2 | 64 | David BartlettOTHER | 1 | Jul 20, 2020 | clinicaltrials |
| NCT04341337 | Link of Interest and Training Model | completed | — | 5 | Centre de l'arthrose, ParisOTHER | 1 | Apr 29, 2020 | clinicaltrials |
| NCT03805971 | Probe Based Confocal Laser Endomicroscopy During Thoracoscopy for Pleural Malignancies Diagnosis. | completed | — | 65 | University of LiegeOTHER | 1 | Apr 3, 2020 | clinicaltrials |
Data updated 5 days agoSource updated Sep 21, 2026source: clinicaltrials